ALK Mutation Status in EGFR-negative Non-small-cell Lung Cancer Patients in Bulgaria

Affiliations

Djambazov Slaveyko N.: Faculty of Public Health, Medical University, Pleven, Bulgaria
Vekov Toni Y.: Faculty of Public Health, Medical University, Pleven, Bulgaria
Mekov Evgeni V.: Clinical Center for Pulmonary Diseases, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria
Slavchev Georgi S.: Health Technology Assessment Institute LTD, Sofia, Bulgaria
Petkov Rosen E.: Clinical Center for Pulmonary Diseases, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria
Kostadinov Dimitar T.: Clinical Center for Pulmonary Diseases, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria
Konteva Ljubliana T.: Faculty of Public Health, Medical University, Pleven, Bulgaria

Abstract

Background: Patients with non-small-cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK) rearrangement mutation are found to be 3–13%.